While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments.

The ideas and opinions expressed in these Data Supplements do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in ...

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

Robust survivorship care is important because cancer patients have a unique set of medical needs,” said Melissa Erickson, MD.

MDX2004 is designed to activate T cells through three unique signalling pathways to enhance immune activation.

Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study POSITIVE is a prospective trial ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid tumors. Several oncology companies announced key trial milestones this week ...

In June, Orange, Calif.-based UCI Health tapped Gary Deng, MD, PhD, as director of the Integrative Oncology program at the UCI Health Chao Family Comprehensive Cancer Center, in partnership with the ...

The leading professional organization for European oncologists has rolled out its first set of guidance on how its members ...

The 5th Binaytara Precision Oncology Summit, a two-day conference chaired by Dr. Mark Pegram, convenes in San Francisco on October 24-25, 2025. The summit is dedicated to redefining cancer treatment ...

Q3 2025 Management View CEO Anthony Zook highlighted record clinical volumes and revenues for the third quarter of 2025, emphasizing the company’s progress in next-generation sequencing (NGS) and ...